Light Emitting Headphones: A Dubious Solution for Seasonal Depression, Experts Say


In a world where the pursuit of well-being intersects with technology, the latest trend claims to offer relief from seasonal affective disorder (SAD) through light emitting headphones. However, experts caution against the efficacy of these gadgets, emphasizing the lack of solid evidence supporting their therapeutic benefits.

As the darker months often trigger feelings of sadness, sunlight exposure has been a well-known remedy for combating seasonal depression. For those unable to access sufficient sunlight, light therapy boxes have emerged as a popular alternative.

However, a new player in the market involves earbuds that act as miniature flashlights, purportedly directing light into the ear canals to impact the brain positively. The question on everyone’s mind: Are these devices legitimate?

Light Emitting Headphones For SAD

A recent TikTok video by skincare influencer @emmahoareau1 showcased her review of LED headphones, claiming they were “absolutely life-changing” for individuals experiencing seasonal affective disorder. The video gained traction, sparking a debate about whether the emitted light can genuinely reach the brain and, if so, whether it has any meaningful impact.

The surprising answer to the first question is yes. Decades of scientific study, dating back to a 1963 experiment, have shown that light can penetrate brain tissues. Researchers used a light detector, akin to a mini solar panel, attached to a needle inserted into the brains of various animals, both living and deceased. The results indicated that light can easily reach the brain, particularly through the temples where the bone is thinner.

Additionally, the presence of light-detecting proteins in different body parts, including the brain, has been documented. While these proteins play a role in helping birds discern seasons, their significance in humans, especially in the context of seasonal mood disorders, remains unclear.

In 2016, researchers provided further evidence that light in the ear canals can have a detectable impact on the brain. However, the question of whether this effect is beneficial or merely detectable remains unanswered.

Despite the acknowledgment that light can reach the brain, the leap from this scientific fact to the claim that these headphones can cure seasonal affective disorder presents a considerable gap. The prominent light therapy headset featured in the TikTok video is manufactured by Valkee, with their current product, the HumanCharger, priced at $200.

Valkee commissioned multiple studies on their product, and although they heavily relied on these studies in their early marketing efforts, scrutiny revealed significant shortcomings.

A 2012 television program in Finland exposed conflicts of interest, inadequate placebos, and a lack of peer-reviewed publications in Valkee’s studies. While their website previously made bold claims about treating conditions like migraines and jet lag, the current iteration avoids such assertions.

Subsequent research has failed to provide more promising results. A 2014 study, authored by Valkee employees and shareholders, lacked a control group and did not support the claim that the device decreased depression scores. Another study on circadian rhythm found no significant difference between individuals using the Valkee device and a sham version.

In light of these findings, experts emphasize the lack of robust evidence supporting the efficacy of light-up earbuds in alleviating seasonal affective disorder. While emotional-support placebos may bring relief to some, consumers are advised to exercise caution and save their money, considering the questionable nature of these devices.

As the debate continues, the scientific community remains skeptical about the transformative potential of light-emitting headphones in addressing the complexities of seasonal depression.

— Share —

— About the Author —

Leave a Reply

Up Next

Study Reveals Significant Genetic Link Between Treatment-Resistant Depression and Family History

In a groundbreaking study published in the journal JAMA Psychiatry, researchers have uncovered a substantial genetic link between treatment-resistant depression (TRD) and family history.

Led by Dr. Cheng-Ta Li, a professor of medicine at the National Yang-Ming Chiao Tung University in Taipei, Taiwan, the study utilized extensive national health insurance data to investigate the transmission of TRD across generations and its association with other psychiatric disorders.

The findings of the study are particularly significant, as they shed light on the hereditary nature of TRD and its implications for early intervention and treatment.

Up Next

FDA Clears Prescription Digital Therapeutic for Adults with Major Depressive Disorder

The FDA has recently cleared a groundbreaking prescription digital therapeutic, known as Rejoyn, for the treatment of major depressive disorder (MDD) symptoms in adults. This innovative therapy, developed by Otsuka Pharmaceutical Co. Ltd. in collaboration with Click Therapeutics Inc., aims to provide adjunctive care for individuals who have been prescribed antidepressants as part of clinician-managed outpatient treatment.

Rejoyn is a 6-week treatment program designed to assist individuals aged 22 years and older in regulating their emotions through a combination of clinically validated cognitive training exercises and therapeutic lessons.

The therapy utilizes digital platforms to deliver pe

Up Next

Sweet Science: How Chocolate’s Theobromine May Aid Weight Loss and Alzheimer’s Prevention

A recent study conducted by researchers at Zhengzhou University in China suggests that indulging in chocolate could offer various health benefits, including weight loss assistance and Alzheimer’s prevention.

Published in the Journal of Functional Foods, the study highlights the potential of a chemical compound found in chocolate called theobromine to positively impact both the body and the brain.

Theobromine, present in cocoa beans, boasts anti-inflammatory properties and is rich in antioxidants, making it beneficial for brain health. According to scientists, this compound can protect against Alzhei

Up Next

New Study Finds High Genetic Risk for Obesity May Require Over 14,500 Daily Steps

A recent study published in JAMA Network Open reveals a significant association between genetic risk for obesity and the amount of physical activity required to mitigate the risk.

Led by Dr. Evan Brittain, associate professor of medicine at Vanderbilt University Medical Center, the study analyzed data from 3,124 participants in the National Institutes of Health’s All of Us Research Program to explore the link between genetic predisposition to obesity and recommended step counts for reducing the genetic risk of developing the condition.

Findings from the study indicate that individuals with a higher genetic risk of obesity may need to undertake more physical activity

Up Next

Ketogenic Diets Show Promise for Bipolar Disorder and Schizophrenia Treatment, Stanford Study Finds

A recent study led by researchers at Stanford University suggests that ketogenic diets may offer benefits for individuals with bipolar disorder and schizophrenia, shedding light on the potential role of diet in managing serious mental illnesses.

The findings, published in Psychiatry Research, highlight the positive impact of a ketogenic regime on both psychiatric outcomes and metabolic syndromes commonly associated with these conditions.

Unlike traditional diets, ketogenic diets are characterized by high fat, moderate protein, and very low carbohydrate intake. The study, led by Dr. Shebani Sethi, a clinical ass

Up Next

Trend Alert: “Patientsplaining” on the Rise as Americans Share Online Health Research with Doctors

A recent survey conducted by market research company OnePoll for Vimergy sheds light on a growing trend among Americans dubbed as “patientsplaining,” where individuals discuss their online health findings with their doctors. The survey, which included 2,000 general population Americans, explored how people invest time in their health and interact with healthcare professionals.

According to the findings, seven in 10 Americans (68%) admit to engaging in “patiensplaining,” wherein they share their online health research with their doctors. This behavior reflects a broader trend of increased interest and involvement in personal health matters, with three in four respondents (77%) reporting that they conduct health-related research in their spare time.

Prevalence of Patientsplaining

Up Next

New Study Raises Concerns About Impact of Metformin on Offspring’s Brain Development During Pregnancy

In a groundbreaking study shedding light on the complexities of managing gestational diabetes risks, researchers from the German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE) have uncovered potential concerns regarding the impact of metformin on offspring’s brain development during pregnancy.

Published in the prestigious journal Molecular Metabolism, this research underscores the urgent need for preventive strategies and careful consideration of treatment options for pregnant individuals with diabetes.

Rising Cases of Gestational Diabetes

With the prevalence of gestational diabetes and metabolic disorders on the rise during pregnancy, the prescription of metformin has become increasingly common. However, the effects of this oral antidiabetic medication on the developing brain of